✦ LIBER ✦

Overcoming the loss of efficacy of tamoxifen in breast cancer

Book ID: 120872072
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1999
Weight: 267 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-199912030-00014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tamoxifen lacks efficacy in receptor neg

Tamoxifen lacks efficacy in receptor negative breast cancer

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Tamoxifen efficacy in breast cancer affe

Tamoxifen efficacy in breast cancer affected by CYP2 genotype

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Vandetanib increases the efficacy of tam

Vandetanib increases the efficacy of tamoxifen in a preclinical luminal breast cancer model

✍ Spanheimer, Philip; Park, Jung M.; Askeland, Ryan W.; Cyr, Anthony R.; Woodfield 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Influence of CYP2D6-genotype on tamoxife

Influence of CYP2D6-genotype on tamoxifen efficacy in advanced breast cancer

✍ Karle, Jennifer; Bolbrinker, Juliane; Vogl, Silvia; Kreutz, Reinhold; Denkert, C 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 359 KB

Tamoxifen in the Treatment of Breast Can

Tamoxifen in the Treatment of Breast Cancer

✍ Wood, Alastair J.J.; Osborne, C. Kent 📂 Article 📅 1998 🏛 Massachusetts Medical Society 🌐 English ⚖ 141 KB

Efficacy of UFT plus Tamoxifen for Estro

Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer

✍ Dr Masami Ogita, Junichi Uchino, Kazuaki Asaishi, Yoshihiko Kubo, Tatsuzo Tanabe 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 129 KB